Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Angiochem Inc patents


Recent patent applications related to Angiochem Inc. Angiochem Inc is listed as an Agent/Assignee. Note: Angiochem Inc may have other listings under different names/spellings. We're not affiliated with Angiochem Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Angiochem Inc-related inventors


Methods for the treatment of leptomeningeal carcinomatosis

The present invention features a method of treating leptomeningeal carcinomatosis in a subject using a peptide-therapeutic conjugate as exemplified by the agent ang1005.. . ... Angiochem Inc

Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof

The present invention relates to short polypeptides (e.g., fewer than 19 amino acids in length) and longer polypeptides (e.g., 19 or more amino acids in length) having one or more d-amino acids as targeting moieties. These polypeptides, when conjugated to agents (e.g., therapeutic agents or transport vectors) are capable of transporting the agents across the bbb or into particular cell types. ... Angiochem Inc

Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin

The present invention relates to antibody-polypeptide-cytotoxin conjugates and methods of making, packaging, and using the conjugates. The polypeptide can be a kunitz-type protease inhibitor or a derivative thereof that facilitates transport of the conjugate across the blood-brain barrier and/or into cancer cells outside the cns, and the antibody moiety selectively binds a target within the cns or in peripheral tumors to direct the cytotoxic agent to that target (e.g., a tumor or cancer cell). ... Angiochem Inc

Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin

The present invention relates to antibody-polypeptide-cytotoxin conjugates and methods of making, packaging, and using the conjugates. The polypeptide can be a kunitz-type protease inhibitor or a derivative thereof that facilitates transport of the conjugate across the blood-brain barrier and/or into cancer cells outside the cns, and the antibody moiety selectively binds a target within the cns or in peripheral tumors to direct the cytotoxic agent to that target (e.g., a tumor or cancer cell). ... Angiochem Inc

Delivery of antibodies to the central nervous system

The invention relates to improvements in the field of drug delivery. More particularly, the invention relates to polypeptide derived from aprotinin and from aprotinin analogs as well as conjugates and pharmaceutical compositions comprising these polypeptides. ... Angiochem Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Angiochem Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Angiochem Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###